Mirvie RNA Platform Predicts Severe Fetal Growth Restriction Months Before Birth
The Mirvie RNA platform identified a unique molecular signature predictive of severe fetal growth restriction, allowing early detection.
Read MorePosted by Andy Lundin | Jan 30, 2025 | Womens Health |
The Mirvie RNA platform identified a unique molecular signature predictive of severe fetal growth restriction, allowing early detection.
Read MorePosted by Chris Wolski | Jan 15, 2025 | Miscellaneous |
Following a People-to-People trip to Cuba, CLP Chief Editor Chris Wolski gained a more nuanced view of the Cuban healthcare system.
Read MorePosted by Andy Lundin | Dec 20, 2024 | Molecular Diagnostics, Pancreatic |
PharusDx announced a liquid biopsy test that uses microRNA and CA19-9 biomarkers to detect early-stage pancreatic cancer.
Read MorePosted by Andy Lundin | Dec 9, 2024 | Diabetes & Metabolic Diseases |
Researchers have identified two types of metabolic-associated fatty liver disease (MASLD), offering insights for improved diagnosis.
Read MorePosted by Andy Lundin | Nov 15, 2024 | Kidney Disease, Urine Analyzers |
Healthy.io’s kidney test demonstrated 96.4% sensitivity in detecting albuminuria, showcasing its potential to improve early detection of CKD.
Read More